Quality of medicines for life-threatening pregnancy complications in low-and middle-income countries: a systematic review
MR Torloni, M Bonet, AP Betran, CC Ribeiro-do-Valle… - PLoS …, 2020 - journals.plos.org
Background There are concerns about the quality of medicines available in low-and middle-
income countries (LMIC) to manage hemorrhage, pre-eclampsia/eclampsia and sepsis. We …
income countries (LMIC) to manage hemorrhage, pre-eclampsia/eclampsia and sepsis. We …
Oxytocin quality: evidence to support updated global recommendations on oxytocin for postpartum hemorrhage
P Lambert, MP McIntosh, M Widmer, L Evans… - … of Pharmaceutical Policy …, 2020 - Springer
Background The use of quality injectable oxytocin effectively prevents and treats postpartum
hemorrhage, the leading cause of maternal death worldwide. In low-and middle-income …
hemorrhage, the leading cause of maternal death worldwide. In low-and middle-income …
Quality of oxytocin and tranexamic acid for the prevention and treatment of postpartum hemorrhage in Kenya, Nigeria, South Africa, and Tanzania
A Ammerdorffer, S Rushwan, R Timms… - … of Gynecology & …, 2022 - Wiley Online Library
Objective To check the quality of oxytocin and tranexamic acid—two recommended products
for prevention and treatment of postpartum hemorrhage (PPH)—used in facilities taking part …
for prevention and treatment of postpartum hemorrhage (PPH)—used in facilities taking part …
[HTML][HTML] Stability of oxytocin preparations in Malawi and Rwanda: stabilizing effect of chlorobutanol
N Hagen, T Bizimana, PC Kayumba… - The American Journal …, 2020 - ncbi.nlm.nih.gov
Oxytocin is used for the prevention and treatment of postpartum hemorrhage, the leading
cause of maternal mortality in low-and middle-income countries. Because of the high …
cause of maternal mortality in low-and middle-income countries. Because of the high …